The Enterprise Value as of June 2026 (TTM) for Pluristem Therapeutics Inc. (PSTI) is 43.64M

According to Pluristem Therapeutics Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 43.64M. This represents a change of -33.94% compared to the average of 66.06M of the last 4 quarters.

Pluristem Therapeutics Inc. (PSTI) Historical Enterprise Value (quarterly & annually)

How has PSTI Enterprise Value performed in the past?

The mean historical Enterprise Value of Pluristem Therapeutics Inc. over the last ten years is 122.57M. The current 43.64M Enterprise Value has changed 3.46% with respect to the historical average. Over the past ten years (40 quarters), PSTI's Enterprise Value was at its highest in in the September 2020 quarter at 263.70M. The Enterprise Value was at its lowest in in the December 2024 quarter at 11.05M.

Pluristem Therapeutics Inc. (PSTI) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Pluristem Therapeutics Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Pluristem Therapeutics Inc. (PSTI) Average Enterprise Value

How has PSTI Enterprise Value performed in the past?

The current Enterprise Value of Pluristem Therapeutics Inc. (PSTI) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Pluristem Therapeutics Inc. (PSTI) Enterprise Value vs. Peers

How is PSTI’s Enterprise Value compared to its peers?

Pluristem Therapeutics Inc.’s Enterprise Value is greater than Magenta Therapeutics, Inc. (-583861976.00), greater than Rein Therapeutics Inc. (27.26M), greater than Eyenovia, Inc. (15.27M), greater than Satsuma Pharmaceuticals, Inc. (20.18M), greater than Lumos Pharma, Inc. (3.04M), greater than Lunai Bioworks Inc. (9.18M), less than GreenLight Biosciences Holdings (57.81M), greater than Cerecor Inc. (13.64M), greater than LianBio (8.07M), less than AlloVir, Inc. (47.97M),

Build a custom stock screener for Pluristem Therapeutics Inc. (PSTI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pluristem Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Pluristem Therapeutics Inc. (PSTI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Pluristem Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.